Showing 1971-1980 of 8180 results for "".
Approaches to AK Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approaches-to-ak-management/20133/When confronted with AK, dermatologists are armed with various treatment options, including destructive and field-directed therapies. Vishal Patel, MD and Neal Bhatia, MD talk about their approach to decision-making.Skin Checks and Patient Education on Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-checks-and-patient-education-on-actinic-keratoses/20132/During skin checks, it's important for dermatologists to educate patients, especially younger ones, about the extent of sun damage and the benefits of field treatments. Anthony Rossi, MD and Vishal Patel, MD discuss their approaches.Cosmetic Controversies: A CSF Update from the 2019 Meeting
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-controversies-a-csf-update/20121/Some of the leading minds in cosmetic surgery weigh in on the ongoing controversies in aesthetic patient care. David Goldberg, MD, JD, Zakia Rhaman, MD, Hema Sundaram, MD, and Julie Woodward, MD talk lasers, injectables, and influencers.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitFive ways marketing can fight the winter practice doldrums
https://practicaldermatology.com/topics/practice-management/five-ways-marketing-can-fight-the-winter-practice-doldrums/20036/The holiday season creeps up on us earlier and earlier each year. Let’s resolve to be prepared! You can fight the slow season and winter doldrums by marketing to what makes this time of the year so special. There no longer has to be a slowdown. You can be busy year-round – and that is reason to cele5 Year Plan: Innovation Update
https://practicaldermatology.com/conferences/asds-2021/5-year-plan-innovation-update/20024/Mat Avram, MD provides an update on newly approved technologies as well as some that could be in use in practice within the next five years to improve outcomes or increase safety.Make Your Mark: Formulate a Product Line
https://practicaldermatology.com/topics/practice-management/make-your-mark-formulate-a-product-line/20023/Dispensing skincare offers benefits to your practice and your patients. Joel Schlessinger, MD discusses his journey with his son to developing their own product formulation and offers insights and encourages colleagues to use their unique talents to do the same.DERM2021: The Right Meeting For All Derm PAs/NPs
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-the-right-meeting-for-all-derm-pasnps/19964/Kristine Kucera, PA-C, MPAS, DHS says all dermatology physician assistants and nurse practitioners should be attending this year’s DERM2021 NP/PA CME Conference. She discusses the unique educational opportunities and access to top-notch presenters available at this meeting.Managing Skin Disease in Cancer Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-skin-disease-in-cancer-patients/19927/Skin reactions to cancer therapeutics can lead to difficult-to-manage rashes. Biologics can present an effective, appropriate option, but dermatologists need to know which biologics to select and when. Anisha Patel, MD provides an overview.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.